The Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity
Top Cited Papers
- 12 November 2007
- journal article
- review article
- Published by Elsevier in Toxicology
- Vol. 246 (1) , 24-33
- https://doi.org/10.1016/j.tox.2007.10.029
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- Sites of alkylation of human Keap1 by natural chemoprevention agentsJournal of the American Society for Mass Spectrometry, 2007
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Nrf2-mediated protection against 6-hydroxydopamineBrain Research, 2007
- Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signalingThe EMBO Journal, 2006
- Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicityBiochemical and Biophysical Research Communications, 2005
- Nrf2 Regulates Thromboxane Synthase Gene Expression in Human Lung CellsDNA and Cell Biology, 2003
- Functional Characterization of Transcription Regulators That Interact with the Electrophile Response ElementBiochemical and Biophysical Research Communications, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Inhibition of the 26S Proteasome Induces Expression of GLCLC, the Catalytic Subunit for γ-Glutamylcysteine SynthetaseBiochemical and Biophysical Research Communications, 2000
- Up-Regulation of the Human γ-Glutamylcysteine Synthetase Regulatory Subunit Gene Involves Binding of Nrf-2 to an Electrophile Responsive ElementBiochemical and Biophysical Research Communications, 1999